Incyte | INCY - Modal Dan Cadangan





Modal Dan Cadangan Perubahan Tanggal
Acadia Pharmaceuticals USD 1.25B 20.68M 2026-03
Agenus USD -221.22M 49.89M 2026-03
Agios Pharmaceuticals USD 1.03B 83.09M 2026-06
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
Amgen USD 9.19B 532M 2026-03
BioCryst Pharmaceuticals USD -553.84M 434.69M 2026-03
Biogen USD 18.85B 196.3M 2026-06
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Eli Lilly USD 31.2B 4.66B 2026-03
Exelixis USD 1.94B 225.57M 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
Incyte USD 6.34B 721.58M 2026-06
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
MacroGenics USD 21.2M 34.39M 2026-03
Merck USD 45.88B 6.73B 2026-03
Moderna USD 6.76B 647M 2026-06
Nektar Therapeutics USD 576.22M 486.38M 2026-03
Neurocrine Biosciences USD 3.69B 286.2M 2026-06
Novartis USD 41.95B 3.02B 2026-06
Novartis USD 38.93B 7.2B 2026-03
Pfizer USD 85.19B 4.91B 2026-06
PTC Therapeutics USD -165.36M 15.1M 2026-06
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Sarepta Therapeutics USD 1.51B 364.48M 2026-03
Ultragenyx Pharmaceutical USD -236M 156M 2026-03
Vertex Pharmaceuticals USD 20.25B 886M 2026-06